CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income	$ 57,567	$ 25,102
Adjustments to reconcile net income to net cash provided by operating activities:
(Credit) provision for credit losses	(6,899)	37,213
Depreciation and amortization of premises and equipment	5,160	4,628
Non-cash lease (benefit) expense	(81)	176
Cash flows from operating leases	(4,927)	(4,743)
Loss on disposal of fixed assets	38	0
Loss on sale of other real estate, net of write-downs	0	70
Amortization of mortgage servicing rights	2,800	4,558
Net amortization and accretion of premium/discounts on investment securities	7,557	7,127
Share-based compensation expense	2,437	2,725
Investment securities gains (losses)	(150)	352
Net gain on sales of residential mortgage loans	(4,469)	(9,971)
Proceeds from sales of loans held for sale	113,094	287,924
Originations of loans held for sale	(97,228)	(292,832)
Equity in earnings of unconsolidated subsidiaries	(299)	(234)
Distributions from unconsolidated subsidiaries	368	225
Net increase in cash surrender value of bank-owned life insurance	(3,357)	(2,253)
Deferred income taxes	(2,961)	(6,953)
Net tax benefit (expense) from share-based compensation	256	(157)
Net change in other assets and liabilities	6,009	(12,547)
Net cash provided by operating activities	74,915	40,410
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available-for-sale	229,868	237,632
Proceeds from sales of investment securities available-for-sale	279,539	86,508
Purchases of investment securities available-for-sale	(900,427)	(351,701)
Net loan repayments (originations)	126,449	(546,954)
Purchases of loan portfolios	(209,916)	(39,876)
Proceeds from sale of foreclosed loans/other real estate owned	0	94
Purchases of bank-owned life insurance	(3,550)	0
Proceeds from bank-owned life insurance	2,107	166
Net purchases of premises, equipment and land	(20,110)	(19,380)
Contributions to unconsolidated subsidiaries	(2,912)	(2,936)
Net proceeds from redemption (purchases) of FHLB stock	285	(2,485)
Net cash used in investing activities	(498,667)	(638,932)
Cash flows from financing activities:
Net increase in deposits	719,745	558,906
Proceeds from long-term debt	0	65,944
Repayments of Long-term Debt	0	65,944
Net (decrease) increase in short-term borrowings	(22,000)	56,000
Cash dividends paid on common stock	(20,010)	(19,453)
Repurchases of common stock and other related costs	(10,221)	(4,749)
Net proceeds from issuance of common stock and stock option exercises	1,013	0
Net cash provided by financing activities	668,527	590,704
Net increase (decrease) in cash and cash equivalents	244,775	(7,818)
Cash and cash equivalents at beginning of period	104,067	102,972
Cash and cash equivalents at end of period	348,842	95,154
Cash paid during the period for:
Interest	5,777	14,988
Income taxes	20,377	15,803
Supplemental disclosure of non-cash information:
Net change in common stock held by directors’ deferred compensation plan	191	218
Net reclassification of loans to foreclosed loans/other real estate owned	0	128
Net transfer of loans to loans held for sale	$ 0	$ 6,565

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.